5AM Ventures clocks in with filing for new $240 mln fund
Menlo Park, Calif.-based life sciences investor 5AM Ventures has filed with the Securities and Exchange Commission to raise $240 million for Fund IV. The firm, which primarily invests in early-stage life sciences, raised $220 million for Fund III, which closed in 2009, according to data from Thomson Reuters (publisher of peHUB). That fund invested in Relypsa, a Redwood City, Calif.-based developer of drugs to treat cardiovascular and renal disease and which is currently in registration for an expected $126.5 million IPO.
17 October 2013•1 min read
